SUTRO BIOPHARMA, INC. - FORM S-1 - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - August 29, 2018

Attached files

file filename
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - SUTRO BIOPHARMA, INC.d553197dex211.htm
EX-10.16 - COMMON STOCK PURCHASE AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex1016.htm
EX-10.14 - LOAN AND SECURITY AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex1014.htm
EX-10.12 - EMD SERONO LICENSE AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex1012.htm
EX-10.10 - STANDARD INDUSTRIAL/COMMERCIAL LEASE - SUTRO BIOPHARMA, INC.d553197dex1010.htm
EX-10.9 - EDGEWATER BUSINESS PARK LEASE - SUTRO BIOPHARMA, INC.d553197dex109.htm
EX-10.8 - TREVOR HALLAM OFFER LETTER - SUTRO BIOPHARMA, INC.d553197dex108.htm
EX-10.7 - ARTURO MOLINA OFFER LETTER - SUTRO BIOPHARMA, INC.d553197dex107.htm
EX-10.6 - WILLIAM NEWELL OFFER LETTER - SUTRO BIOPHARMA, INC.d553197dex106.htm
EX-10.3 - 2017 CALL OPTION PLAN AND FORMS OF AWARD AGREEMENTS - SUTRO BIOPHARMA, INC.d553197dex103.htm
EX-10.2 - 2004 STOCK PLAN AND FORMS OF AWARD AGREEMENTS - SUTRO BIOPHARMA, INC.d553197dex102.htm
EX-4.5 - FORM OF WARRANT TO PURCHASE SERIES D-2 PREFERRED STOCK - SUTRO BIOPHARMA, INC.d553197dex45.htm
EX-4.4 - FORMS OF WARRANT TO PURCHASE SERIES C PREFERRED STOCK - SUTRO BIOPHARMA, INC.d553197dex44.htm
EX-4.3 - FORM OF WARRANT TO PURCHASE SHARES OF COMMON STOCK - SUTRO BIOPHARMA, INC.d553197dex43.htm
EX-4.2(B) - OMNIBUS AMENDMENT AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex42b.htm
EX-4.2(A) - AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex42a.htm
EX-4.1 - FORM OF COMMON STOCK CERTIFICATE - SUTRO BIOPHARMA, INC.d553197dex41.htm
EX-3.3 - PRE-IPO BYLAWS - SUTRO BIOPHARMA, INC.d553197dex33.htm
EX-3.1 - PRE-IPO CERTIFICATE OF INCORPORATION - SUTRO BIOPHARMA, INC.d553197dex31.htm
S-1 - S-1 - SUTRO BIOPHARMA, INC.d553197ds1.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 1, 2018, in the Registration Statement (Form S-1) and related Prospectus of Sutro Biopharma, Inc. dated August 29, 2018.

/s/ Ernst & Young LLP

Redwood City, California

August 29, 2018

SUTRO BIOPHARMA, INC. Reports

Also read